15% OFF IGF-1 LR3 – 1mg/vial (Research Use Only)
Long-acting IGF-1 analog studied in protein-synthesis and body-composition research. Research use only.
Availability: In stock
3–4 vials — 5% off · 5–9 vials — 10% off · 10+ vials — 15% off
Applied automatically in the cart. Combines with a discount code up to 20% off in total, and stacks on top of the subscription discount.
Research Disclaimer: All products currently listed on this site are for research purposes only.
Overview
IGF-1 LR3 (Long-Arginine-3 IGF-1) is a synthetic long-acting analogue of human insulin-like growth factor 1 (IGF-1) engineered for research applications requiring extended receptor activation and reduced IGFBP binding. By substituting glutamate at position 3 with arginine and prepending a 13-amino acid extension peptide at the N-terminus, IGF-1 LR3 achieves markedly reduced binding to IGF-binding proteins (IGFBPs) and a correspondingly extended plasma half-life compared to native IGF-1 — making it the preferred research tool for sustained IGF-1 receptor pathway studies.
What It Is
IGF-1 LR3 is an 83-amino acid synthetic analogue of human IGF-1, incorporating a 13-residue N-terminal extension and a Glu³→Arg substitution. Its molecular weight is approximately 9,117 Da. It has ~2–3% of the IGFBP binding affinity of native IGF-1, resulting in an estimated half-life of 20–30 hours in vivo versus the ~12-minute half-life of native IGF-1. CAS number: 946870-92-4.
Key Research Applications
- IGF-1 receptor (IGF-1R) activation, downstream PI3K/Akt/mTOR signaling research
- Myoblast proliferation, differentiation, and skeletal muscle tissue culture studies
- Satellite cell activation and muscle regeneration pathway research
- Bone anabolic signaling, osteoblast function, and skeletal growth research
- Long-acting IGF-1 analogue pharmacokinetics and IGFBP interaction studies
- GH/IGF-1 axis dissociation studies — GH-independent IGF-1R activation research
- Neuroprotection, neuronal survival, and CNS IGF-1 receptor biology
- Comparative pharmacology vs. native IGF-1 and des(1-3) IGF-1 fragments
Technical Specifications
| Amino Acids | 83 |
| Molecular Weight | ~9,117 Da |
| CAS Number | 946870-92-4 |
| Mechanism | IGF-1 Receptor Agonist (Extended Half-Life) |
| IGFBP Binding | ~2–3% of native IGF-1 |
| Purity | ≥98% (supplier specification) |
| Form | Lyophilized powder |
| Vial Size | 1mg |
| Storage | −4 °F long-term |
FOR RESEARCH USE ONLY. Not intended for human or veterinary consumption, medical diagnosis, treatment, or prevention of any disease or condition. This product has not been evaluated by the FDA or any regulatory agency. Must be handled by qualified research personnel in a compliant laboratory setting. These statements have not been evaluated by the Food and Drug Administration.
Not sure which compounds fit your research? Browse the Research Hub →
- Processing: Orders ship within 1–2 business days
- Domestic delivery: 3–5 business days via USPS Priority / UPS Ground
- Free shipping on orders over $100
- Temperature handling: Cold-chain packaging available on request for lyophilized peptides
- Tracking: Emailed automatically at time of dispatch
- Store lyophilized (dry) peptides at −4 °F for long-term stability
- Protect from light and moisture at all times
- Do not freeze
- Where the Storage row in the product specification above differs, follow the specification
Frequently Asked Questions
IGF-1 LR3 is a modified analogue of insulin-like growth factor 1 with an N-terminal extension and an arginine substitution that reduce binding to IGF-binding proteins, giving it a longer half-life than native IGF-1. It is widely used as an IGF-1 receptor agonist in cell-culture and growth-factor signalling research. Portal to Wellness does not publish protocols, combinations or quantities, and nothing on this page is a recommendation for use.
Pairs Well With
Related research products
Reviews
There are no reviews yet.